Axa’s Ares Capital ARCC Stock Holding History

Axa’s Portfolio ARCC Stock Details ARCC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-43,155	Closed	-$948K	–	138
2025 Q2	$948K	Hold	43,155	–	–	﹤0.01%	901
2025 Q1	$956K	Buy	43,155 +777	+2%	+$17.6K	﹤0.01%	853
2024 Q4	$928K	Buy	+42,378	New	+$914K	﹤0.01%	875

Other funds holding ARCC

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

GAM

Generali Asset Management Trieste, Italy $5.53B AUM 35.1% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Axa's ARCC Position: Q3 2025 in Review

Axa sold out of Ares Capital (ARCC) in Q3 2025, closing a stake of 43,155 shares — an estimated $948K sold.

Axa first reported a position in ARCC in Q4 2024 and held it in 3 quarters. The position peaked at $956K in Q1 2025. 790 funds tracked by Wall St. Rank hold ARCC as of Q3 2025.

Axa reported no remaining Ares Capital position as of Q3 2025 after selling out during the quarter.
Axa sold 43,155 Ares Capital shares in Q3 2025, an estimated $948K.
Axa first reported a position in Ares Capital in Q4 2024 and held it in 3 quarters.
Axa's Ares Capital position peaked at $956K in Q1 2025.
790 funds tracked by Wall St. Rank held Ares Capital as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.